查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092082

電腦輔助檢測市場－2026-2032年全球市場預測

Computer Aided Detection Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，電腦輔助偵測 (CAD) 市場將成長至 143,396 億美元，複合年成長率為 5.64%。

主要市場統計數據
基準年 2025 9.7645億美元
預計年份：2026年 1,035,450,000 美元
預測年份 2032 1,433,960,000 美元
複合年成長率 (%) 5.64%

電腦輔助偵測 (CADe)執行摘要

電腦輔助檢測 (CADe) 正逐漸成為現代診斷成像的重要組成部分，它能夠自動識別包括乳房X光攝影、乳房攝影篩檢成像、電腦斷層掃描 (CT)、磁振造影(MRI)、超音波和內視鏡檢查在內的各種影像模式下的可疑觀察，從而輔助超音波和臨床醫生進行診斷。這項技術旨在提高病灶檢出率，合理分配診斷影像的工作量，降低漏診風險，並在日益複雜的醫療環境中規範診斷解讀。癌症篩檢數量的增加、斷層掃描的廣泛應用、人口老化以及全球診斷放射科醫生的短缺，都在推動對這項技術的需求。在臨床實務中，當電腦輔助檢測整合到影像歸檔和通訊系統 (PACS)、放射資訊系統 (RIS) 以及企業級影像工作流程中時，其價值最為顯著，能夠在不干擾既定報告流程的情況下加快影像審查速度。監管機構對醫療設備軟體、臨床檢驗、網路安全、互通性和上市後監測的重視，正在影響這項技術的應用前景。隨著醫療保健系統向價值導向型醫療轉變，CADe 作為決策支援工具變得越來越重要，它能夠提高診斷一致性，促進疾病的早期發現，並有助於最佳化影像資源，同時將最終的診斷決策置於合格臨床醫生的監督之下。

電腦輔助偵測（CADe）領域的變革性變化

電腦輔助偵測 (CADe) 領域正從獨立的影像分析工具轉向整合到工作流程中的診斷支援平台。早期的 CADE 解決方案通常專注於有限的應用場景，特別是乳癌篩檢，而目前的部署擴大涵蓋肺結節、結直腸息肉、神經系統異常、心血管成像、骨折和多器官疾病的檢測。醫院和影像中心優先考慮能夠與現有臨床系統無縫整合、符合 DICOM 標準並在常規影像判讀工作流程中提供結果的解決方案。另一個重大轉變是從基於規則的影像處理轉向基於大規模標註資料集訓練的機器學習和深度學習模型。雖然這種轉變提高了多種影像應用的靈敏度，但臨床應用仍取決於證據品質、演算法透明度、對不同患者群體的普適性以及監管部門的批准。保險報銷、臨床醫生的信心、問責制和資料管治仍然是影響應用的關鍵因素。基於雲端的部署、聯邦學習、邊緣運算和廠商中立的企業影像也在重塑部署模式，使醫療機構能夠在解決隱私和基礎設施限制的同時擴展其診斷支援。

人工智慧對電腦輔助檢測的累積影響

人工智慧正透過提升模式識別能力、優先處理急診病例以及在診斷量大的環境中實現更一致的觀察解讀，對電腦輔助檢測 (CADe) 產生累積影響。深度學習演算法能夠識別常規影像閱片中難以發現的細微影像特徵，這在異常觀察相對罕見的篩檢項目中尤其效用。人工智慧驅動的電腦輔助檢測 (CADe) 正被擴大用於標記肺結節、乳房病變、顱內出血、骨折、結直腸息肉和其他具有臨床意義的異常情況。其影響不僅限於檢測準確性；人工智慧還能透過對檢查進行分診、縮短關鍵觀察的預警時間以及幫助放射科醫生處理日益成長的未處理影像量來支援工作流程的調整。然而，循證實施需要前瞻性檢驗、代表性資料集、偏差評估、性能監測以及與臨床指南的一致性。主要醫療保健市場的監管機構正在加強對人工智慧驅動的醫療軟體的監管，明確了其預期用途、風險分類、品管、實際性能和變更管理等方面的要求。最完善的電腦輔助診斷和評估（CADe）策略將人工智慧定位為“增強智慧”，結合演算法檢測、放射科醫生專業知識、多學科管治和持續安全監測。

電腦輔助檢測的關鍵區域見解

在亞太地區，由於診斷基礎設施的不斷完善、龐大的患者群體、國家級癌症篩檢舉措以及對數位醫療投入的增加，電腦輔助檢測技術正迅速發展。中國、日本、韓國、印度和澳洲是人工智慧影像工具的領先應用國，其臨床應用已擴展到肺癌、乳癌、中風、結核病和胃腸道疾病的檢測。北美地區在電腦輔助檢測技術的應用方面依然非常活躍，這得益於成熟的成像網路、完善的醫療設備軟體監管流程、積極的學術檢驗活動以及企業成像基礎設施的廣泛應用。在美國和加拿大，臨床證據、互通性、網路安全和保險報銷的協調性是採購決策的關鍵考慮因素。在拉丁美洲，隨著巴西、墨西哥和其他國家利用遠距遠端醫療擴大放射學能力和影像服務覆蓋範圍，電腦輔助檢測技術正穩步發展，但基礎設施和專家資源的差異正在影響其應用模式。在歐洲，該系統受益於系統性的篩檢計畫、強大的放射學會和嚴格的資料保護法規，而歐洲醫療設備和人工智慧管治的法規結構正在推動其應用。在中東，對數位化醫院、先進影像設備和國家醫療轉型計畫的投資正在穩步推進，尤其是在海灣國家，這些國家致力於透過人工智慧提高診斷效率。非洲在結核病和癌症篩檢以及遠端放射診斷方面看到了電腦輔助檢測（CAD）的獨特機會。在專家稀缺的地區，擴充性且檢驗的決策支援工具尤其重要，前提是基礎設施、通訊能力、成本效益和本地資料集的代表性能夠得到保障。

小組對電腦輔助檢測的關鍵見解

在東南亞國協，隨著各國政府推動醫療數位化、擴大癌症篩檢覆蓋範圍以及提升公立和私立醫療系統的遠距放射學能力，電腦輔助檢測（CADe）的重要性日益凸顯。各國部署情況不盡相同，一些先進的醫院網路整合了人工智慧驅動的影像輔助服務，而新興系統則專注於可擴展的乳房攝影篩檢影像、結核病篩檢和腫瘤治療路徑工具。海灣合作理事會（GCC）國家正透過國家數位健康戰略、對智慧醫院的投資以及對高通量診斷服務的需求，加速CADe的普及應用，尤其注重互通性、資料安全和高品質的臨床基礎設施。歐盟（EU）正透過協調醫療設備法規、資料保護要求、健康資料空間計畫以及加強對可靠人工智慧的監管，塑造CADe環境，使臨床證據和上市後監測成為CADe普及應用的關鍵。金磚國家（BRICS）則正在為電腦輔助檢測（CADe）帶來規模化和多樣性。中國和印度優先發展大規模篩檢和診斷，巴西正在加強其影像網路，俄羅斯正在提升其區域數位醫療能力，而南非則強調需要人工智慧工具來彌補專科醫生能力的不足。七國集團（G7）憑藉其先進的影像能力、成熟的監管體系、深厚的臨床研究以及對人工智慧驅動的放射學工作流程的早期應用，仍然保持著重要的影響力。北約成員國的醫療保健系統與北美和歐洲的高所得國家的醫療保健系統存在顯著的重疊，這些國家的採購通常側重於韌性、網路安全、安全的雲端基礎設施以及民用和國防相關醫療保健系統的連續性。

各國對電腦輔助檢測的深入了解

美國在電腦輔助檢測（CADe）的臨床部署密度方面處於世界領先地位，這得益於先進的影像技術、人工智慧驅動的醫療軟體的監管審查、強大的醫療資訊技術整合以及放射學和腫瘤學領域積極的臨床研究。加拿大強調循證部署、與省級醫療保健系統的整合以及負責任的人工智慧管治，尤其是在服務於地域分散人群的放射學網路中。在墨西哥，數位醫療和影像技術的普及為CADe在腫瘤學、乳房攝影篩檢和遠距放射學領域的部署創造了機會。巴西是拉丁美洲最重要的影像市場之一，擁有大規模的醫院系統，並且對人工智慧輔助檢測癌症和肺部疾病的興趣日益濃厚。在英國，人工智慧的部署正透過國家健康數位化計畫、影像網路以及專注於安全性、工作流程影響和臨床有效性的評估框架不斷推進。在德國，完善的醫院基礎設施、醫療技術基礎和嚴格的法規為CADe的部署提供了支持，並確保了資料保護、互通性和檢驗標準的滿足。法國優先發展數位醫療、評估醫療人工智慧並提高癌症篩檢質量，而義大利和西班牙則利用電腦輔助診斷（CADe）技術，在擁有成熟影像服務的區域醫療保健系統中提升診斷效率。俄羅斯持續發展其國內數位醫療和人工智慧影像能力，並專注於放射學自動化及其在公共衛生領域的應用。中國憑藉其龐大的影像資料量、國家人工智慧優先政策以及對可擴展診斷支援的需求，已成為人工智慧驅動型醫學影像開發和部署的重要中心。印度的需求受其龐大的患者群體、放射科醫生分佈不均以及不斷擴展的公立和私立診斷網路的影響，CADe 在乳房攝影篩檢、結核病、癌症篩檢和超音波等工作流程中發揮關鍵作用。日本在其高度發展的醫學影像環境中採用 CADe 技術，特別關注癌症、消化器官系統疾病和老齡化相關疾病的檢測。澳洲憑藉其成熟的數位醫療體系、完善的放射學網路以及為偏遠地區人口提供醫療保健的需求，大力推進 CADe 的部署。韓國擁有先進的醫院系統、強大的技術基礎設施和活躍的醫療人工智慧研究，使其成為在醫學影像的多個專業領域採用人工智慧驅動的電腦輔助檢測（CADe）的領先國家。

為電腦輔助檢測領域的領導者提供的實用建議

產業領導者應優先考慮經過臨床檢驗的電腦輔助檢測解決方案，這些方案需展現出可衡量的流程價值、卓越的診斷性能以及與現有影像環境的安全整合。成功的策略始於選擇重點臨床應用場景，使電腦輔助檢測（CADe）能夠應對特定挑戰，例如大規模篩檢、急診分流、肺乳房攝影檢測、乳房X光檢查、中風預警和大腸鏡檢查輔助。各機構應要求提供基於代表性資料集、外部檢驗和實際效能監測的證據，以降低演算法偏差和效能漂移的風險。與PACS、RIS、電子健康記錄和報告系統的互通性應被視為核心採購標準，而不僅僅是部署細節。領導者還需要建立管治框架，以明確臨床醫生的職責、升級流程、網路安全措施、資料隱私義務以及部署後審計程序。對放射科醫生、放射技師和轉診醫生進行培訓至關重要，以確保正確使用並贏得信任。對於供應商和解決方案開發人員而言，區分關鍵因素包括監管合規性、透明的性能文件、可解釋性、可擴展的部署選項以及對持續品質改進的支援。與醫院、學術機構和公共衛生計畫夥伴關係可以加強檢驗，使演算法適應當地環境，並加速負責任的部署。

調查方法

本執行摘要採用系統性的二手研究途徑編寫，重點關注已檢驗、公開且業界認可的資訊來源。該調查方法涵蓋了關於軟體和人工智慧驅動的醫療技術作為醫療設備的監管指南、同行評審的臨床文獻、放射學出版刊物、公共衛生篩檢指南、醫院數位轉型趨勢以及政府醫療技術舉措。評估證據與電腦輔助檢測 (CAD) 應用的相關性，涵蓋各種影像模式、臨床專科、部署模式、區域部署趨勢和管治要求。本分析避免了推測性的市場規模估算、收入預測、佔有率計算或未來預測；而是專注於已檢驗的促進因素、監管因素、臨床應用案例、基礎設施建設和技術趨勢。為提高可靠性，關鍵主題在多個資訊來源類別中進行交叉檢驗，包括臨床檢驗研究、監管資料庫、公共政策文件、醫學影像標準和醫療保健系統數位化專案。區域、群體和國家/地區特定的見解以說明解釋的形式整合，以支持策略決策，同時遵循循證報告標準。

結論

電腦輔助檢測 (CADe) 正從一項小眾的診斷輔助功能發展成為人工智慧驅動的醫學影像和精準診斷的核心要素。其價值在於幫助臨床醫生更早發現具有臨床意義的異常情況，應對日益成長的影像數據量，並提高整個篩檢和診斷流程的一致性。雖然在監管清晰、數位影像基礎設施完善、臨床檢驗和工作流程整合良好的地區，CADe 的應用最為廣泛，但對於那些面臨專科醫生短缺和公共衛生篩檢需求不斷成長的地區而言，這項技術也至關重要。人工智慧正在加速 CADe 的功能和應用範圍，但永續成長需要負責任的部署、代表性的資料集、透明的證據以及持續的部署後監測。醫療服務提供者、政策制定者和技術開發人員若能將 CADe 與臨床優先事項、互通性標準、資料管治和可衡量的患者照護結果相結合，便能最大限度地發揮其在現代診斷影像中的長期價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 電腦輔助偵測市場：依組件分類

  • 軟體
    • 獨立式電腦輔助檢測軟體
    • 基於PACS的整合解決方案
  • 服務
    • 安裝與整合
    • 維護和支援

第8章：電腦輔助檢測市場：依影像方式分類

  • CT
  • MRI
  • PET
  • 超音波
  • X光

第9章：電腦輔助偵測市場：依部署模式分類

  • 基於雲端的
  • 現場
  • 混合

第10章：電腦輔助偵測市場：依應用領域分類

  • 癌症檢測
    • 乳癌
    • 肺癌
    • 攝護腺癌
  • 心血管疾病的檢測
  • 神經系統疾病的檢測
  • 肺部疾病的檢測
    • 結核
    • 肺炎
  • 肌肉骨骼疾病的檢測
    • 斷裂
    • 骨質疏鬆症
  • 消化系統疾病的檢測

第11章：電腦輔助偵測市場：依最終使用者分類

  • 門診手術中心
  • 醫院
    • 民眾
    • 私人的
  • 專科診所
  • 診斷影像中心
  • 學術研究機構

第12章：電腦輔助檢測市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：電腦輔助偵測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：電腦輔助檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agfa-Gevaert Group
  • Aidence BV
  • Aidoc Medical Ltd
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • CureMetrix, Inc.
  • DeepC Health GmbH
  • EDDA Technology, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • IBM Corporation
  • iCAD, Inc.
  • InVivo Corporation
  • Koninklijke Philips NV
  • Lunit Inc.
  • Median Technologies SA
  • Quibim SL
  • Qure.ai Technologies Private Limited
  • Riverain Technologies LLC
  • Samsung Medison Co., Ltd.
  • ScreenPoint Medical BV
  • Siemens Healthineers AG
  • United Imaging Healthcare Co., Ltd.
  • Volpara Health Technologies Limited
  • Vuno Inc.
  • Zebra Medical Vision Ltd
Product Code: MRR-385067DD9C86

The Computer Aided Detection Market is projected to grow by USD 1,433.96 million at a CAGR of 5.64% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 976.45 million
Estimated Year [2026] USD 1,035.45 million
Forecast Year [2032] USD 1,433.96 million
CAGR (%) 5.64%

Computer Aided Detection Executive Summary

Computer aided detection (CADe) is becoming a critical layer in modern diagnostic imaging, supporting radiologists and clinicians by automatically identifying suspicious findings across modalities such as mammography, chest imaging, computed tomography, magnetic resonance imaging, ultrasound, and endoscopy. The technology is designed to improve lesion detection, triage imaging workloads, reduce oversight risk, and standardize diagnostic interpretation in increasingly complex care environments. Demand is reinforced by rising cancer screening volumes, expanding use of cross-sectional imaging, aging populations, and global shortages of imaging specialists. In clinical practice, computer aided detection is most valuable when integrated into picture archiving and communication systems, radiology information systems, and enterprise imaging workflows, enabling faster review without disrupting established reporting routines. Regulatory emphasis on software as a medical device, clinical validation, cybersecurity, interoperability, and post-market surveillance is shaping adoption pathways. As healthcare systems move toward value-based care, CADe is gaining relevance as a decision-support tool that can improve diagnostic consistency, support early disease detection, and help optimize imaging resources while keeping the final diagnostic decision under qualified clinical oversight.

Transformative Shifts in the Computer Aided Detection Landscape

The computer aided detection landscape is shifting from standalone image analysis tools toward embedded, workflow-native diagnostic support platforms. Earlier generations of CADe were often focused on narrow use cases, especially breast cancer screening, whereas current deployments increasingly address lung nodules, colorectal polyps, neurological abnormalities, cardiovascular imaging, bone fractures, and multi-organ disease detection. Hospitals and imaging centers are prioritizing solutions that integrate seamlessly with existing clinical systems, support DICOM standards, and deliver results within routine reading workflows. Another major transformation is the movement from rule-based image processing toward machine learning and deep learning models trained on large annotated datasets. This shift has improved sensitivity across several imaging applications, although clinical adoption still depends on evidence quality, algorithm transparency, generalizability across patient populations, and regulatory clearance. Reimbursement, clinician trust, liability management, and data governance remain central adoption factors. Cloud-based deployment, federated learning, edge computing, and vendor-neutral enterprise imaging are also reshaping implementation models, enabling institutions to scale diagnostic support while addressing privacy and infrastructure constraints.

Cumulative Impact of Artificial Intelligence on Computer Aided Detection

Artificial intelligence is having a cumulative impact on computer aided detection by improving pattern recognition, prioritizing urgent cases, and enabling more consistent interpretation across high-volume diagnostic settings. Deep learning algorithms can identify subtle image features that may be difficult to detect during routine review, particularly in screening programs where abnormal findings are relatively infrequent. AI-enabled CADe is increasingly used to flag pulmonary nodules, breast lesions, intracranial hemorrhage, fractures, colon polyps, and other clinically significant abnormalities. The impact is not limited to detection accuracy; AI can also support workflow orchestration by triaging studies, reducing time-to-alert for critical findings, and helping radiology departments manage growing imaging backlogs. However, evidence-based adoption requires prospective validation, representative datasets, bias assessment, performance monitoring, and alignment with clinical guidelines. Regulators in major healthcare markets have strengthened oversight of AI-driven medical software, with requirements related to intended use, risk classification, quality management, real-world performance, and change control. The most resilient CADe strategies are those that treat AI as augmented intelligence, combining algorithmic detection with radiologist expertise, multidisciplinary governance, and continuous safety monitoring.

Key Regional Insights for Computer Aided Detection

Asia-Pacific is advancing rapidly in computer aided detection due to expanding diagnostic infrastructure, large patient populations, national cancer screening initiatives, and increasing investment in digital health. China, Japan, South Korea, India, and Australia are prominent adopters of AI-enabled imaging tools, with clinical interest spanning lung cancer, breast cancer, stroke, tuberculosis, and gastrointestinal disease detection. North America remains a highly active region for CADe adoption, supported by mature imaging networks, established regulatory pathways for software as a medical device, strong academic validation activity, and widespread use of enterprise imaging infrastructure. The United States and Canada emphasize clinical evidence, interoperability, cybersecurity, and reimbursement alignment in procurement decisions. Latin America is showing steady progress as Brazil, Mexico, and other countries expand radiology capacity and telemedicine-enabled imaging access, although uneven infrastructure and specialist availability influence deployment models. Europe benefits from structured screening programs, strong radiology societies, and rigorous data protection rules, with adoption shaped by the European regulatory framework for medical devices and AI governance. The Middle East is investing in digital hospitals, advanced imaging equipment, and national health transformation programs, particularly in Gulf countries seeking AI-enabled diagnostic efficiency. Africa presents a distinct opportunity for computer aided detection in tuberculosis, cancer screening, and remote radiology support, where constrained specialist availability makes scalable, validated decision-support tools especially relevant, provided that infrastructure, connectivity, affordability, and local dataset representation are addressed.

Key Group Insights for Computer Aided Detection

ASEAN countries are increasingly relevant to computer aided detection as governments expand healthcare digitization, cancer screening access, and tele-radiology capacity across diverse public and private systems. Adoption varies by country, with more advanced hospital networks integrating AI-enabled imaging support while emerging systems focus on scalable tools for chest imaging, tuberculosis screening, and oncology pathways. GCC countries are accelerating CADe integration through national digital health strategies, investments in smart hospitals, and demand for high-throughput diagnostic services, with a strong emphasis on interoperability, data security, and premium clinical infrastructure. The European Union is shaping the CADe environment through harmonized medical device regulation, data protection requirements, health data space initiatives, and growing scrutiny of trustworthy AI, making clinical evidence and post-market monitoring essential for adoption. BRICS countries bring scale and diversity to computer aided detection, with China and India emphasizing high-volume screening and diagnostic access, Brazil strengthening imaging networks, Russia advancing local digital health capabilities, and South Africa highlighting the need for AI tools that support limited specialist capacity. G7 countries remain influential because of advanced imaging utilization, regulatory maturity, clinical research depth, and early adoption of AI-enabled radiology workflows. NATO member countries overlap significantly with high-income healthcare systems in North America and Europe, where procurement often emphasizes resilience, cybersecurity, secure cloud infrastructure, and continuity of care across civilian and defense-related health systems.

Key Country Insights for Computer Aided Detection

The United States leads in clinical deployment intensity for computer aided detection, supported by advanced imaging utilization, regulatory review of AI-enabled medical software, strong health IT integration, and active clinical research across radiology and oncology. Canada emphasizes evidence-based adoption, provincial health system integration, and responsible AI governance, especially in radiology networks serving geographically dispersed populations. Mexico is expanding digital health and imaging access, creating opportunities for CADe in oncology, chest imaging, and tele-radiology-supported diagnostics. Brazil is one of Latin America's most important imaging markets, with large hospital systems and growing interest in AI-assisted detection for cancer and pulmonary disease. The United Kingdom is advancing AI adoption through national health digitization programs, imaging networks, and evaluation frameworks focused on safety, workflow impact, and clinical effectiveness. Germany's strong hospital infrastructure, medical technology base, and regulatory rigor support CADe adoption where data protection, interoperability, and validation standards are met. France is prioritizing digital health, medical AI evaluation, and cancer screening quality, while Italy and Spain are applying CADe to improve diagnostic efficiency across regional health systems with established imaging services. Russia continues to develop domestic digital health and AI imaging capabilities, with emphasis on radiology automation and public health use cases. China is a major center for AI-enabled medical imaging development and deployment, driven by large imaging volumes, national AI priorities, and demand for scalable diagnostic support. India's needs are shaped by a high patient burden, uneven radiologist distribution, and expanding private and public diagnostic networks, making CADe relevant for chest imaging, tuberculosis, cancer screening, and ultrasound-supported workflows. Japan is adopting CADe within a highly advanced medical imaging environment, with strong interest in cancer, gastrointestinal, and aging-related disease detection. Australia's adoption is supported by digital health maturity, radiology network consolidation, and the need to serve remote populations. South Korea combines advanced hospital systems, strong technology infrastructure, and active medical AI research, making it a significant adopter of AI-enabled computer aided detection across multiple imaging specialties.

Actionable Recommendations for Computer Aided Detection Leaders

Industry leaders should prioritize clinically validated computer aided detection solutions that demonstrate measurable workflow value, strong diagnostic performance, and safe integration into existing imaging environments. Successful strategies begin with selecting focused clinical use cases where CADe can address clear pain points, such as high-volume screening, emergency triage, lung nodule detection, breast imaging review, stroke alerts, or colonoscopy support. Organizations should require evidence from representative datasets, external validation, and real-world performance monitoring to reduce the risk of algorithmic bias and performance drift. Interoperability with PACS, RIS, electronic health records, and reporting systems should be treated as a core purchasing criterion rather than an implementation detail. Leaders should also establish governance frameworks that define clinician responsibility, escalation workflows, cybersecurity controls, data privacy obligations, and post-deployment audit procedures. Training radiologists, technologists, and referring clinicians is essential to ensure appropriate use and trust. For vendors and solution developers, differentiation depends on regulatory readiness, transparent performance documentation, explainability features, scalable deployment options, and support for continuous quality improvement. Partnerships with hospitals, academic centers, and public health programs can strengthen validation, localize algorithms, and accelerate responsible adoption.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified, publicly available, and industry-recognized sources. The methodology includes review of regulatory guidance for software as a medical device and AI-enabled medical technologies, peer-reviewed clinical literature, radiology society publications, public health screening guidelines, hospital digital transformation trends, and government health technology initiatives. Evidence is assessed for relevance to computer aided detection applications across imaging modalities, clinical specialties, deployment models, regional adoption dynamics, and governance requirements. The analysis avoids speculative market sizing, revenue estimation, share calculation, or forecasting, and instead focuses on validated adoption drivers, regulatory factors, clinical use cases, infrastructure readiness, and technology trends. Key themes are cross-checked across multiple source categories to improve reliability, including clinical validation studies, regulatory databases, public policy documents, medical imaging standards, and health system digitization programs. Regional, group, and country insights are synthesized into narrative interpretation to support strategic decision-making while maintaining compliance with evidence-based reporting standards.

Conclusion

Computer aided detection is evolving from a niche diagnostic support function into a core component of AI-enabled medical imaging and precision diagnostics. Its value lies in helping clinicians detect clinically meaningful abnormalities earlier, manage rising imaging volumes, and improve consistency across screening and diagnostic workflows. Adoption is strongest where regulatory clarity, digital imaging infrastructure, clinical validation, and workflow integration are well established, but the technology also has significant relevance in regions facing specialist shortages and expanding public health screening needs. Artificial intelligence is accelerating CADe performance and scope, yet sustainable growth depends on responsible implementation, representative datasets, transparent evidence, and continuous monitoring after deployment. Healthcare providers, policymakers, and technology developers that align CADe with clinical priorities, interoperability standards, data governance, and measurable patient-care outcomes will be best positioned to capture its long-term value in modern diagnostic imaging.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Computer Aided Detection Market, by Component

  • 7.1. Introduction
  • 7.2. Software
    • 7.2.1. Standalone Computer Aided Detection Software
    • 7.2.2. Integrated PACS Based Solutions
  • 7.3. Services
    • 7.3.1. Installation & Integration
    • 7.3.2. Maintenance & Support

8. Computer Aided Detection Market, by Imaging Modality

  • 8.1. Introduction
  • 8.2. CT
  • 8.3. MRI
  • 8.4. PET
  • 8.5. Ultrasound
  • 8.6. X Ray

9. Computer Aided Detection Market, by Deployment Mode

  • 9.1. Introduction
  • 9.2. Cloud based
  • 9.3. On premise
  • 9.4. Hybrid

10. Computer Aided Detection Market, by Application

  • 10.1. Introduction
  • 10.2. Cancer Detection
    • 10.2.1. Breast Cancer
    • 10.2.2. Lung Cancer
    • 10.2.3. Prostate Cancer
  • 10.3. Cardiovascular Disease Detection
  • 10.4. Neurological Disorder Detection
  • 10.5. Pulmonary Disease Detection
    • 10.5.1. Tuberculosis
    • 10.5.2. Pneumonia
  • 10.6. Musculoskeletal Disorder Detection
    • 10.6.1. Fractures
    • 10.6.2. Osteoporosis
  • 10.7. Gastrointestinal Disorder Detection

11. Computer Aided Detection Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals
    • 11.3.1. Public
    • 11.3.2. Private
  • 11.4. Specialty Clinics
  • 11.5. Diagnostic Imaging Centers
  • 11.6. Academic & Research Institutes

12. Computer Aided Detection Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Computer Aided Detection Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Computer Aided Detection Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agfa-Gevaert Group
  • 16.2. Aidence B.V.
  • 16.3. Aidoc Medical Ltd
  • 16.4. Brainlab AG
  • 16.5. Canon Medical Systems Corporation
  • 16.6. Carestream Health, Inc.
  • 16.7. CureMetrix, Inc.
  • 16.8. DeepC Health GmbH
  • 16.9. EDDA Technology, Inc.
  • 16.10. Esaote S.p.A.
  • 16.11. FUJIFILM Holdings Corporation
  • 16.12. GE HealthCare Technologies Inc.
  • 16.13. Hologic, Inc.
  • 16.14. IBM Corporation
  • 16.15. iCAD, Inc.
  • 16.16. InVivo Corporation
  • 16.17. Koninklijke Philips N.V.
  • 16.18. Lunit Inc.
  • 16.19. Median Technologies S.A.
  • 16.20. Quibim S.L.
  • 16.21. Qure.ai Technologies Private Limited
  • 16.22. Riverain Technologies LLC
  • 16.23. Samsung Medison Co., Ltd.
  • 16.24. ScreenPoint Medical B.V.
  • 16.25. Siemens Healthineers AG
  • 16.26. United Imaging Healthcare Co., Ltd.
  • 16.27. Volpara Health Technologies Limited
  • 16.28. Vuno Inc.
  • 16.29. Zebra Medical Vision Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPUTER AIDED DETECTION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL COMPUTER AIDED DETECTION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL COMPUTER AIDED DETECTION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL COMPUTER AIDED DETECTION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL COMPUTER AIDED DETECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL COMPUTER AIDED DETECTION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL COMPUTER AIDED DETECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STANDALONE COMPUTER AIDED DETECTION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STANDALONE COMPUTER AIDED DETECTION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STANDALONE COMPUTER AIDED DETECTION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTEGRATED PACS BASED SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTEGRATED PACS BASED SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTEGRATED PACS BASED SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INSTALLATION & INTEGRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INSTALLATION & INTEGRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INSTALLATION & INTEGRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MRI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MRI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MRI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL X RAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL X RAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL X RAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CANCER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CANCER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CANCER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BREAST CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BREAST CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LUNG CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LUNG CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LUNG CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PROSTATE CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PROSTATE CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PROSTATE CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIOVASCULAR DISEASE DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIOVASCULAR DISEASE DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIOVASCULAR DISEASE DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGICAL DISORDER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGICAL DISORDER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGICAL DISORDER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PULMONARY DISEASE DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PULMONARY DISEASE DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PULMONARY DISEASE DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TUBERCULOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TUBERCULOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TUBERCULOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PNEUMONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PNEUMONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PNEUMONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MUSCULOSKELETAL DISORDER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MUSCULOSKELETAL DISORDER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MUSCULOSKELETAL DISORDER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FRACTURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FRACTURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FRACTURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL OSTEOPOROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL OSTEOPOROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL OSTEOPOROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL DISORDER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL DISORDER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL DISORDER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 198. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 200. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GCC COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 234. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 236. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 240. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 241. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 249. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. NATO COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL COMPUTER AIDED DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 299. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED KINGDOM COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 317. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 319. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 321. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 322. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 323. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 324. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 325. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 326. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 327. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 329. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 331. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 332. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 333. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 334. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 335. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 336. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY CANCER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 337. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY PULMONARY DISEASE DETECTION, 2018-2032 (USD MILLION)
  • TABLE 338. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY MUSCULOSKELETAL DISORDER DETECTION, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE COMPUTER AIDED DETECTION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 341. RUSSIA COMPUTER AIDED DETECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA COMPUTER AIDED DETECTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA COMPUTER AIDED DETECTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA COMPUTER AIDED DETECTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA COMPUTER AIDED DETECTION MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
  • TABLE 346. RUSSIA COMPUTER AIDED DETECTION